Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin

PLoS One. 2010 Feb 18;5(2):e9258. doi: 10.1371/journal.pone.0009258.

Abstract

Background: The Notch pathway is essential for proper epidermal differentiation during embryonic skin development. Moreover, skin specific loss of Notch signaling in the embryo results in skin barrier defects accompanied by a B-lymphoproliferative disease. However, much less is known about the consequences of loss of Notch signaling after birth.

Methodology and principal findings: To study the function of Notch signaling in the skin of adult mice, we made use of a series of conditional gene targeted mice that allow inactivation of several components of the Notch signaling pathway specifically in the skin. We demonstrate that skin-specific inactivation of Notch1 and Notch2 simultaneously, or RBP-J, induces the development of a severe form of atopic dermatitis (AD), characterized by acanthosis, spongiosis and hyperkeratosis, as well as a massive dermal infiltration of eosinophils and mast cells. Likewise, patients suffering from AD, but not psoriasis or lichen planus, have a marked reduction of Notch receptor expression in the skin. Loss of Notch in keratinocytes induces the production of thymic stromal lymphopoietin (TSLP), a cytokine deeply implicated in the pathogenesis of AD. The AD-like associated inflammation is accompanied by a myeloproliferative disorder (MPD) characterized by an increase in immature myeloid populations in the bone marrow and spleen. Transplantation studies revealed that the MPD is cell non-autonomous and caused by dramatic microenvironmental alterations. Genetic studies demontrated that G-CSF mediates the MPD as well as changes in the bone marrow microenvironment leading to osteopenia.

Significance: Our data demonstrate a critical role for Notch in repressing TSLP production in keratinocytes, thereby maintaining integrity of the skin and the hematopoietic system.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytokines / metabolism
  • Dermatitis, Atopic / genetics
  • Dermatitis, Atopic / mortality
  • Dermatitis, Atopic / physiopathology*
  • Flow Cytometry
  • Granulocyte Colony-Stimulating Factor / genetics
  • Granulocyte Colony-Stimulating Factor / metabolism
  • Humans
  • Immunoglobulins
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Nude
  • Mice, Transgenic
  • Models, Biological
  • Myeloproliferative Disorders / genetics
  • Myeloproliferative Disorders / mortality
  • Myeloproliferative Disorders / physiopathology*
  • Receptor, Notch1 / genetics
  • Receptor, Notch1 / physiology
  • Receptor, Notch2 / genetics
  • Receptor, Notch2 / physiology
  • Receptors, Cytokine / genetics
  • Receptors, Cytokine / metabolism
  • Receptors, Notch / genetics
  • Receptors, Notch / physiology*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / genetics
  • Signal Transduction / physiology*
  • Skin / metabolism
  • Skin / pathology
  • Skin / physiopathology*
  • Survival Analysis
  • Survival Rate
  • Thymic Stromal Lymphopoietin

Substances

  • Cytokines
  • Immunoglobulins
  • Notch1 protein, mouse
  • Notch2 protein, mouse
  • Receptor, Notch1
  • Receptor, Notch2
  • Receptors, Cytokine
  • Receptors, Notch
  • Tslpr protein, mouse
  • Granulocyte Colony-Stimulating Factor
  • Thymic Stromal Lymphopoietin